In this episode of MedtronicTalks, Que Dallara, EVP and President of the Diabetes Business at Medtronic, discusses the company's recent advancements in diabetes management.
Dallara, transitioning from the software and technology industry to the medical device industry, draws parallels between control systems in different fields and their application to diabetes management, particularly in the development of closed-loop algorithms for insulin dosing. She also highlights the FDA-approved MiniMed 780G system, which simplifies diabetes management with automatic adjustments for insulin dosing and carbohydrate counting. Finally, Dallara addresses Medtronic's ongoing engagement with the FDA and news of the launch of the MiniMed 780G system in the U.S., sharing more about its meal detection technology and benefits.
Thank you to GlobalMed-MDI for sponsoring this episode. To learn more about how GlobalMed-MDI works with medical device companies, visit www.moldeddevices.com.
Thank you for listening to the Medtronic Podcast.
Subscribe to this podcast on every major podcast platform.
All content for MedtronicTalks is the property of Tom Salemi and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of MedtronicTalks, Que Dallara, EVP and President of the Diabetes Business at Medtronic, discusses the company's recent advancements in diabetes management.
Dallara, transitioning from the software and technology industry to the medical device industry, draws parallels between control systems in different fields and their application to diabetes management, particularly in the development of closed-loop algorithms for insulin dosing. She also highlights the FDA-approved MiniMed 780G system, which simplifies diabetes management with automatic adjustments for insulin dosing and carbohydrate counting. Finally, Dallara addresses Medtronic's ongoing engagement with the FDA and news of the launch of the MiniMed 780G system in the U.S., sharing more about its meal detection technology and benefits.
Thank you to GlobalMed-MDI for sponsoring this episode. To learn more about how GlobalMed-MDI works with medical device companies, visit www.moldeddevices.com.
Thank you for listening to the Medtronic Podcast.
Subscribe to this podcast on every major podcast platform.
Why we need to stop ignoring the equivalent of 747s crashing daily and expand lung cancer screening
MedtronicTalks
36 minutes 12 seconds
3 years ago
Why we need to stop ignoring the equivalent of 747s crashing daily and expand lung cancer screening
This episode shines a light on lung cancer, a deadly killer that isn’t getting the attention it deserves. Dr. William Mayfield, WellStar Health System medical director and former chief surgical officer, says lung cancer kills thousands of people every day – more than most other cancers combined – but isn’t screened for as aggressively. Drawing motivation from a personal loss to lung cancer, Emily Elswick, vice president in the Office of the CEO and former vice president and general manager of Lung Health and Visualization, says we currently have the tools necessary to expand screening, but we need to find the will.
MedtronicTalks
In this episode of MedtronicTalks, Que Dallara, EVP and President of the Diabetes Business at Medtronic, discusses the company's recent advancements in diabetes management.
Dallara, transitioning from the software and technology industry to the medical device industry, draws parallels between control systems in different fields and their application to diabetes management, particularly in the development of closed-loop algorithms for insulin dosing. She also highlights the FDA-approved MiniMed 780G system, which simplifies diabetes management with automatic adjustments for insulin dosing and carbohydrate counting. Finally, Dallara addresses Medtronic's ongoing engagement with the FDA and news of the launch of the MiniMed 780G system in the U.S., sharing more about its meal detection technology and benefits.
Thank you to GlobalMed-MDI for sponsoring this episode. To learn more about how GlobalMed-MDI works with medical device companies, visit www.moldeddevices.com.
Thank you for listening to the Medtronic Podcast.
Subscribe to this podcast on every major podcast platform.